Macular degeneration is a group of eye disease commonly found among children and adults. There are various types of macular degeneration affecting the teens such as Cone-Rod Dystrophy, Best disease, Stargardt disease, Corneal Dystrophy, and Fuch’s Dystrophy.Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved.
This report contains market size and forecasts of Ophthalmology Disorders Drug in Global, including the following market information:
Global Ophthalmology Disorders Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Ophthalmology Disorders Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ophthalmology Disorders Drug include Sanofi, Bayer, Bausch + Lomb, Novartis, Usher Syndrome, Takeda Pharmaceutical, Roche, Pfizer and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ophthalmology Disorders Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmology Disorders Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Ophthalmology Disorders Drug Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
External Use
Global Ophthalmology Disorders Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Ophthalmology Disorders Drug Market Segment Percentages, by Application, 2021 (%)
Juvenile Macular Degeneration (Stargardt Disease)
Leber Congenital Amaurosis (LCA)
Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
Usher Syndrome
Retinitis Pigmentosa (Retinitis)
Global Ophthalmology Disorders Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Ophthalmology Disorders Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmology Disorders Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Ophthalmology Disorders Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Bayer
Bausch + Lomb
Novartis
Usher Syndrome
Takeda Pharmaceutical
Roche
Pfizer
Allergan
Gilead Sciences
Kubota Pharmaceutical
Alkeus Pharmaceuticals
Astellas Pharma
Ferrer Corporate
Amgen Inc
Editas Medicine Inc
ProQR Therapeutics NV
ReNeuron
Amarantus BioScience
Ocugen
ReGenX Biosciences
Sucampo Pharmaceuticals
Orphagen Pharmaceuticals
Okuvision
Second Sight Medical
Acucela
Stealth BioTherapeutics
Sun Pharma Advanced Research Company
AmpliPhi Biosciences
Applied Genetic Technologies
Asklepios BioPharmaceutical
Biovista
Spark Therapeutics
Caladrius Biosciences
Dompe Farmaceutici
Dormant Projects
Grupo Ferrer Internacional
ID Pharma
InFlectis BioScience
Ionis Pharmaceuticals
Ixchel Pharma
Khondrion
Mimetogen Pharmaceuticals
Mitotech
M's Science
Nanovector
SanBio